A citation-based method for searching scientific literature

Lise Román Moltzau, Jan Magnus Aronsen, Silja Meier, Jonas Skogestad, Øivind Ørstavik, Gustav B Lothe, Ivar Sjaastad, Tor Skomedal, Jan-Bjørn Osnes, Finn Olav Levy, Eirik Qvigstad. J Pharmacol Exp Ther 2014
Times Cited: 23







List of co-cited articles
232 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Transgenic mice for real-time visualization of cGMP in intact adult cardiomyocytes.
Konrad R Götz, Julia U Sprenger, Ruwan K Perera, Julia H Steinbrecher, Stephan E Lehnart, Michaela Kuhn, Julia Gorelik, Jean-Luc Balligand, Viacheslav O Nikolaev. Circ Res 2014
45
43

Phosphodiesterase 9A controls nitric-oxide-independent cGMP and hypertrophic heart disease.
Dong I Lee, Guangshuo Zhu, Takashi Sasaki, Gun-Sik Cho, Nazha Hamdani, Ronald Holewinski, Su-Hyun Jo, Thomas Danner, Manling Zhang, Peter P Rainer,[...]. Nature 2015
195
39

Natriuretic peptides increase beta1-adrenoceptor signalling in failing hearts through phosphodiesterase 3 inhibition.
Eirik Qvigstad, Lise R Moltzau, Jan Magnus Aronsen, Cam H T Nguyen, Karina Hougen, Ivar Sjaastad, Finn Olav Levy, Tor Skomedal, Jan-Bjørn Osnes. Cardiovasc Res 2010
45
39

Angiotensin-neprilysin inhibition versus enalapril in heart failure.
John J V McMurray, Milton Packer, Akshay S Desai, Jianjian Gong, Martin P Lefkowitz, Adel R Rizkala, Jean L Rouleau, Victor C Shi, Scott D Solomon, Karl Swedberg,[...]. N Engl J Med 2014
39

Natriuretic peptides, their receptors, and cyclic guanosine monophosphate-dependent signaling functions.
Lincoln R Potter, Sarah Abbey-Hosch, Deborah M Dickey. Endocr Rev 2006
670
34

Differential regulation of C-type natriuretic peptide-induced cGMP and functional responses by PDE2 and PDE3 in failing myocardium.
Lise Román Moltzau, Silja Meier, Jan Magnus Aronsen, Faraz Afzal, Ivar Sjaastad, Tor Skomedal, Jan-Bjørn Osnes, Finn Olav Levy, Eirik Qvigstad. Naunyn Schmiedebergs Arch Pharmacol 2014
14
57

SERCA2 activity is involved in the CNP-mediated functional responses in failing rat myocardium.
L R Moltzau, J M Aronsen, S Meier, C H T Nguyen, K Hougen, Ø Ørstavik, I Sjaastad, G Christensen, T Skomedal, J-B Osnes,[...]. Br J Pharmacol 2013
14
50

Increased effects of C-type natriuretic peptide on cardiac ventricular contractility and relaxation in guanylyl cyclase A-deficient mice.
Melanie Pierkes, Stepan Gambaryan, Peter Bokník, Suzanne M Lohmann, Wilhelm Schmitz, Regine Potthast, Rita Holtwick, Michaela Kuhn. Cardiovasc Res 2002
53
30

Compartmentalized phosphodiesterase-2 activity blunts beta-adrenergic cardiac inotropy via an NO/cGMP-dependent pathway.
Marco Mongillo, Carlo G Tocchetti, Anna Terrin, Valentina Lissandron, York-Fong Cheung, Wolfgang R Dostmann, Tullio Pozzan, David A Kass, Nazareno Paolocci, Miles D Houslay,[...]. Circ Res 2006
213
26



Stress-dependent dilated cardiomyopathy in mice with cardiomyocyte-restricted inactivation of cyclic GMP-dependent protein kinase I.
Stefan Frantz, Michael Klaiber, Hideo A Baba, Heike Oberwinkler, Katharina Völker, Birgit Gaβner, Barbara Bayer, Marco Abeβer, Kai Schuh, Robert Feil,[...]. Eur Heart J 2013
69
26

Microdomain switch of cGMP-regulated phosphodiesterases leads to ANP-induced augmentation of β-adrenoceptor-stimulated contractility in early cardiac hypertrophy.
Ruwan K Perera, Julia U Sprenger, Julia H Steinbrecher, Daniela Hübscher, Stephan E Lehnart, Marco Abesser, Kai Schuh, Ali El-Armouche, Viacheslav O Nikolaev. Circ Res 2015
53
26

Distinct submembrane localisation compartmentalises cardiac NPR1 and NPR2 signalling to cGMP.
Hariharan Subramanian, Alexander Froese, Peter Jönsson, Hannes Schmidt, Julia Gorelik, Viacheslav O Nikolaev. Nat Commun 2018
24
26

Myocardial production of C-type natriuretic peptide in chronic heart failure.
Paul R Kalra, Jonathon R Clague, Aidan P Bolger, Stefan D Anker, Phillip A Poole-Wilson, Allan D Struthers, Andrew J Coats. Circulation 2003
135
21


Cyclic guanosine monophosphate compartmentation in rat cardiac myocytes.
Liliana R V Castro, Ignacio Verde, Dermot M F Cooper, Rodolphe Fischmeister. Circulation 2006
205
21


C-type natriuretic peptide plasma levels increase in patients with chronic heart failure as a function of clinical severity.
Silvia Del Ry, Claudio Passino, Maristella Maltinti, Michele Emdin, Daniela Giannessi. Eur J Heart Fail 2005
73
21

Spatiotemporal dynamics of guanosine 3',5'-cyclic monophosphate revealed by a genetically encoded, fluorescent indicator.
A Honda, S R Adams, C L Sawyer, V Lev-Ram, R Y Tsien, W R Dostmann. Proc Natl Acad Sci U S A 2001
194
21

Beta2-adrenergic receptor redistribution in heart failure changes cAMP compartmentation.
Viacheslav O Nikolaev, Alexey Moshkov, Alexander R Lyon, Michele Miragoli, Pavel Novak, Helen Paur, Martin J Lohse, Yuri E Korchev, Sian E Harding, Julia Gorelik. Science 2010
365
21


Agents increasing cyclic GMP amplify 5-HT4-elicited positive inotropic response in failing rat cardiac ventricle.
Faraz Afzal, Eirik Qvigstad, Jan Magnus Aronsen, Lise Román Moltzau, Ivar Sjaastad, Tor Skomedal, Jan-Bjørn Osnes, Finn Olav Levy. Naunyn Schmiedebergs Arch Pharmacol 2011
18
27

Effects of C-type natriuretic peptide on rat cardiac contractility.
J M Brusq, E Mayoux, L Guigui, J Kirilovsky. Br J Pharmacol 1999
48
21

Gene expression, secretion, and autocrine action of C-type natriuretic peptide in cultured adult rat cardiac fibroblasts.
Takeshi Horio, Takeshi Tokudome, Toshiyuki Maki, Fumiki Yoshihara, Shin-Ichi Suga, Toshio Nishikimi, Masayasu Kojima, Yuhei Kawano, Kenji Kangawa. Endocrinology 2003
132
17

Natriuretic peptide system in human heart failure.
C M Wei, D M Heublein, M A Perrella, A Lerman, R J Rodeheffer, C G McGregor, W D Edwards, H V Schaff, J C Burnett. Circulation 1993
363
17



C-type natriuretic peptide (CNP): a new member of natriuretic peptide family identified in porcine brain.
T Sudoh, N Minamino, K Kangawa, H Matsuo. Biochem Biophys Res Commun 1990
933
17

Sildenafil and B-type natriuretic peptide acutely phosphorylate titin and improve diastolic distensibility in vivo.
Kalkidan Bishu, Nazha Hamdani, Selma F Mohammed, Martina Kruger, Tomohito Ohtani, Ozgur Ogut, Frank V Brozovich, John C Burnett, Wolfgang A Linke, Margaret M Redfield. Circulation 2011
124
17



Increased effects of C-type natriuretic peptide on contractility and calcium regulation in murine hearts overexpressing cyclic GMP-dependent protein kinase I.
Kai C Wollert, Sevdalina Yurukova, Ana Kilic, Frank Begrow, Beate Fiedler, Stepan Gambaryan, Ulrich Walter, Suzanne M Lohmann, Michaela Kuhn. Br J Pharmacol 2003
40
17

Function of cGMP-dependent protein kinases as revealed by gene deletion.
F Hofmann, R Feil, T Kleppisch, J Schlossmann. Physiol Rev 2006
291
17

Fluorescent sensors for rapid monitoring of intracellular cGMP.
Viacheslav O Nikolaev, Stepan Gambaryan, Martin J Lohse. Nat Methods 2006
124
17

Protein kinase A type I and type II define distinct intracellular signaling compartments.
Giulietta Di Benedetto, Anna Zoccarato, Valentina Lissandron, Anna Terrin, Xiang Li, Miles D Houslay, George S Baillie, Manuela Zaccolo. Circ Res 2008
141
17

cGMP signals modulate cAMP levels in a compartment-specific manner to regulate catecholamine-dependent signaling in cardiac myocytes.
Alessandra Stangherlin, Frank Gesellchen, Anna Zoccarato, Anna Terrin, Laura Ashley Fields, Marco Berrera, Nicoletta Concetta Surdo, Margaret Anne Craig, Godfrey Smith, Graham Hamilton,[...]. Circ Res 2011
109
17

Chronic inhibition of cyclic GMP phosphodiesterase 5A prevents and reverses cardiac hypertrophy.
Eiki Takimoto, Hunter C Champion, Manxiang Li, Diego Belardi, Shuxun Ren, E Rene Rodriguez, Djahida Bedja, Kathleen L Gabrielson, Yibin Wang, David A Kass. Nat Med 2005
674
17


Design of fluorescence resonance energy transfer (FRET)-based cGMP indicators: a systematic approach.
Michael Russwurm, Florian Mullershausen, Andreas Friebe, Ronald Jäger, Corina Russwurm, Doris Koesling. Biochem J 2007
93
17

In vivo model with targeted cAMP biosensor reveals changes in receptor-microdomain communication in cardiac disease.
Julia U Sprenger, Ruwan K Perera, Julia H Steinbrecher, Stephan E Lehnart, Lars S Maier, Gerd Hasenfuss, Viacheslav O Nikolaev. Nat Commun 2015
73
17

Low myocardial protein kinase G activity in heart failure with preserved ejection fraction.
Loek van Heerebeek, Nazha Hamdani, Inês Falcão-Pires, Adelino F Leite-Moreira, Mark P V Begieneman, Jean G F Bronzwaer, Jolanda van der Velden, Ger J M Stienen, Gerrit J Laarman, Aernout Somsen,[...]. Circulation 2012
280
17

PDE3 inhibition by C-type natriuretic peptide-induced cGMP enhances cAMP-mediated signaling in both non-failing and failing hearts.
Silja Meier, Kjetil Wessel Andressen, Jan Magnus Aronsen, Ivar Sjaastad, Karina Hougen, Tor Skomedal, Jan-Bjørn Osnes, Eirik Qvigstad, Finn Olav Levy, Lise Román Moltzau. Eur J Pharmacol 2017
16
25

FRET biosensor uncovers cAMP nano-domains at β-adrenergic targets that dictate precise tuning of cardiac contractility.
Nicoletta C Surdo, Marco Berrera, Andreas Koschinski, Marcella Brescia, Matias R Machado, Carolyn Carr, Peter Wright, Julia Gorelik, Stefano Morotti, Eleonora Grandi,[...]. Nat Commun 2017
86
17

C-type natriuretic peptide, a novel antifibrotic and antihypertrophic agent, prevents cardiac remodeling after myocardial infarction.
Takeshi Soeki, Ichiro Kishimoto, Hiroyuki Okumura, Takeshi Tokudome, Takeshi Horio, Kenji Mori, Kenji Kangawa. J Am Coll Cardiol 2005
129
13

Prognostic value of N-terminal pro C-type natriuretic peptide in heart failure patients with preserved and reduced ejection fraction.
Dirk J Lok, Ijsbrand T Klip, Adriaan A Voors, Sjoukje I Lok, Pieta W Bruggink-André de la Porte, Hans L Hillege, Tiny Jaarsma, Dirk J van Veldhuisen, Peter van der Meer. Eur J Heart Fail 2014
30
13


Cardiac fibrosis in end-stage human heart failure and the cardiac natriuretic peptide guanylyl cyclase system: regulation and therapeutic implications.
Tomoko Ichiki, John A Schirger, Brenda K Huntley, Frank V Brozovich, Joseph J Maleszewski, Sharon M Sandberg, S Jeson Sangaralingham, Soon J Park, John C Burnett. J Mol Cell Cardiol 2014
37
13

C-type natriuretic peptide-mediated coronary vasodilation: role of the coronary nitric oxide and particulate guanylate cyclase systems.
R S Wright, C M Wei, C H Kim, M Kinoshita, Y Matsuda, L L Aarhus, J C Burnett, W L Miller. J Am Coll Cardiol 1996
33
13

Regional release and clearance of C-type natriuretic peptides in the human circulation and relation to cardiac function.
Suetonia C Palmer, Timothy C R Prickett, Eric A Espiner, Timothy G Yandle, A Mark Richards. Hypertension 2009
63
13


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.